Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery
Advanced Science · 2026
DOI: 10.1002/advs.202517617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Wenhan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chan Zuckerberg Biohub Chicago, Chicago, IL, 60607, USA. Hauptthemen laut MEDLINE: RNA, Small Interfering, Nanoparticles, Class I Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Society for Advancement of Cytometry, Chan Zuckerberg Biohub, Chan Zuckerberg Initiative.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are useful carriers for therapeutic siRNA delivery, yet their clinical efficacy remains constrained by insufficient cellular uptake. Here, using a genome‐wide CRISPR knockout screen, multiple genetic modulators of LNP uptake is uncovered, with PIK3CA emerging as a top druggable target. Pharmacologic inhibition of PIK3CA with BAY1082439 – a clinically evaluated small molecule – significantly enhances LNP uptake, siRNA delivery, and gene silencing across diverse epithelial cancer cell lines in vitro. Co‐administration of BAY1082439 with siRNA‐loaded LNPs also better suppressed tumor growth and reduced liver inflammation in vivo, respectively. These findings establish PIK3CA inhibition as a broadly applicable strategy to boost LNP‐mediated RNA interference and highlight the promise of combining functional genomics with nanomaterials to advance RNA‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chan Zuckerberg Biohub Chicago, Chicago, IL, 60607, USA.
- Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, IL, 60208, USA.
- School of Integrated Circuits and Electronics, Beijing Institute of Technology, Beijing, 100081, P. R. China.
ORCID-Profile: Zongjie Wang
Förderung
- International Society for Advancement of Cytometry
- Chan Zuckerberg Biohub
- Chan Zuckerberg Initiative
Zitieren
APA
Wang, W., Chen, K., & Wang, Z. (2026). Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery. Advanced Science. https://doi.org/10.1002/advs.202517617
Vancouver
Wang W, Chen K, Wang Z. Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery. Advanced Science. 2026. doi:10.1002/advs.202517617
BibTeX
@article{Wang2026,
author = {Wang, Wenhan and Chen, Kangfu and Wang, Zongjie},
title = {Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517617}
}
EUVIMED